Wednesday, 29 July, 2026г.
russian english deutsch french spanish portuguese czech greek georgian chinese japanese korean indonesian turkish thai uzbek

пример: покупка автомобиля в Запорожье

 

Alan Venook, MD, balancing economics with the efficacy outcomes seen in 80405

Alan Venook, MD, balancing economics with the efficacy outcomes seen in 80405У вашего броузера проблема в совместимости с HTML5
Alan Venook, MD, Professor, Department of Medicine, UCSF Helen Diller Family Comprehensive Cancer Center on balancing economics with efficacy outcomes in 80405 regarding therapeutic decisions for mCRC patients
Опубликовано: 15-06-2016
Похожие видео
Debate 1: First-line Treatment of Metastatic Colorectal Cancer - CALGB 80405

Debate 1: First-line Treatment of Metastatic Colorectal Cancer - CALGB 8040513:18

Prof. Fortunato Ciardiello, MD, PhD, Seconda Università di Napoli

Prof. Fortunato Ciardiello, MD, PhD, Seconda Università di Napoli08:15

Jeffrey A. Meyerhardt, MD discusses the phase 3 CALGB/SWOG 80405 study

Jeffrey A. Meyerhardt, MD discusses the phase 3 CALGB/SWOG 80405 study00:53

Dr. Heinemann on Implications of SIRFLOX Study for mCRC

Dr. Heinemann on Implications of SIRFLOX Study for mCRC01:28

Мой аккаунт

Вход / Log In